vimarsana.com
Home
Live Updates
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 : vimarsana.com
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 -- Axogen, Inc. , a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary...
Related Keywords
United States
,
Canada
,
South Korea
,
Russia
,
Germany
,
United Kingdom
,
Ukraine
,
Spain
,
Karen Zaderej
,
Haroldd Tamayo
,
Axogen Inc
,
Nasdaq
,
Unaudited Fourth Quarter
,
Year End Performance
,
Core Accounts
,
Nerve Graft
,
Soft Tissue
,
Avive Soft Tissue
,
Axoguard Nerve
,
Nerve Protector
,
Private Securities Litigation Reform Act
,
Middle East
,
Annual Report
,
Quarterly Report
,
vimarsana.com © 2020. All Rights Reserved.